PEAK6 Investments’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-11,700
Closed -$564K – 5571
2021
Q3
$564K Buy
+11,700
New +$542K ﹤0.01% 3143
2021
Q2
– Sell
-20,400
Closed -$984K – 5528
2021
Q1
$984K Buy
20,400
+18,200
+827% +$948K ﹤0.01% 2568
2020
Q4
$118K Buy
2,200
+1,600
+267% +$72.3K ﹤0.01% 3976
2020
Q3
$22K Sell
600
-3,500
-85% -$130K ﹤0.01% 4123
2020
Q2
$127K Sell
4,100
-2,700
-40% -$74.8K ﹤0.01% 3693
2020
Q1
$188K Buy
6,800
+100
+1% +$3K ﹤0.01% 2908
2019
Q4
$196K Buy
+6,700
New +$160K ﹤0.01% 2558
2018
Q4
– Sell
-5,900
Closed -$91K – 4441
2018
Q3
$91K Buy
+5,900
New +$81.5K ﹤0.01% 3570

Other funds holding NEO

PEAK6 Investments's NEO Position: Q1 2024 in Review

PEAK6 Investments sold out of NeoGenomics (NEO) in Q1 2024, closing a stake of 14,459 shares — an estimated $223K sold.

PEAK6 Investments first reported a position in NEO in Q3 2018 and held it in 12 quarters. The position peaked at $1.63M in Q2 2019. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.

  • PEAK6 Investments reported no remaining NeoGenomics position as of Q1 2024 after selling out during the quarter.
  • PEAK6 Investments sold 14,459 NeoGenomics shares in Q1 2024, an estimated $223K.
  • PEAK6 Investments first reported a position in NeoGenomics in Q3 2018 and held it in 12 quarters.
  • PEAK6 Investments's NeoGenomics position peaked at $1.63M in Q2 2019.
  • 263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.

Based on PEAK6 Investments's 13F filing for Q1 2024, filed 14 May 2024.